Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Pfizer Inc (PFE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Stock Market News For Nov 22, 2017

Benchmarks finished in the green on Tuesday following gains in the technology and healthcare sectors

GOOGL : 1,051.92 (+0.15%)
AAPL : 174.96 (+1.05%)
KIRK : 12.21 (-6.72%)
FB : 180.87 (-0.54%)
MDT : 82.34 (-0.39%)
PFE : 35.43 (-0.31%)
UNH : 211.22 (-0.65%)
GME : 17.37 (+3.83%)
J&J & Glaxo Get FDA Approval for First Two-Drug HIV Regimen

J&J (JNJ) and Glaxo received FDA approval for Juluca, a two-drug complete regimen of Tivicay/rilpivirine and Edurant/dolutegravir as a single tablet for the treatment of HIV-1 infection.

JNJ : 137.29 (-0.76%)
GILD : 72.82 (+0.43%)
PFE : 35.43 (-0.31%)
GSK : 35.06 (+0.72%)
Amgen (AMGN) Unveils Auto Injector Device for Enbrel in US

Amgen launched its Enbrel Mini with AutoTouch, a new auto injector device for Enbrel in the United States.

NVS : 84.48 (+0.24%)
ABBV : 94.47 (-0.22%)
AMGN : 169.96 (+0.07%)
PFE : 35.43 (-0.31%)
Medical Aesthetics Market Growth Continues to Shine in Healthcare Industry

Medical aesthetics is a fusion of healthcare and beauty services to provide high-technology skin care that involves significant cosmetic change or enhancement. The treatments employed include injections...

VRX.TO : 21.03 (+2.79%)
MRK : 54.37 (+0.18%)
AGN : 174.83 (+2.44%)
MLSS : 1.20 (-4.00%)
VRX : 16.54 (+3.44%)
PFE : 35.43 (-0.31%)
ImmunoPrecise Realigns Senior Management

IMMUNOPRECISE ANTIBODIES LTD. (the "Company") (TSX VENTURE: IPA)(OTC PINK: IPATF) announces the realignment of its senior management team as Dr. James Kuo, Chair of the Board, assumes the interim position...

IPATF : 0.4303 (-13.09%)
SYN : 0.65 (+3.50%)
IPA.VN : 0.570 (-9.52%)
DSCO : 3.50 (-9.33%)
PFE : 35.43 (-0.31%)
Nevada refusing Pfizer demand for return of execution drugs

A Nevada prisons official said Friday the state is refusing pharmaceutical company Pfizer's demand to return a drug it manufactured and not use it in a planned lethal injection execution.

CAH : 56.97 (+2.24%)
PFE : 35.43 (-0.31%)
Nevada wants to use untried execution drugs that pose risks

LAS VEGAS (AP) — For Nevada's first execution in more than a decade, state officials are turning to a never-before-tried combination of drugs, including a powerful painkiller that is fueling much of...

PFE : 35.43 (-0.31%)
The Latest: Nevada won't return execution drug to Pfizer

LINCOLN, Neb. (AP) — The Latest on a pharmaceutical company's demand that states not use drugs it made for lethal injection executions (all times local):

CAH : 56.97 (+2.24%)
PFE : 35.43 (-0.31%)
Pfizer's Cancer Drug Sutent Gets FDA Nod for Label Expansion

Pfizer (PFE) secures an FDA approval for Sutent's label expansion as an adjuvant treatment of recurrent renal cell carcinoma.

NVS : 84.48 (+0.24%)
RHHBY : 31.6600 (+1.90%)
PFE : 35.43 (-0.31%)
BMY : 61.14 (-0.16%)
Cancer Space Update: Label Expansion for Three Major Drugs

This week three major drugs received approval for label expansion in new indications. Moreover, a small biotech launched its first drug as a treatment for kidney cancer.

AVEO : 3.00 (unch)
CELG : 105.16 (+0.63%)
AZN : 33.83 (+0.30%)
BLUE : 167.20 (-0.03%)
MRK : 54.37 (+0.18%)
RHHBY : 31.6600 (+1.90%)
PFE : 35.43 (-0.31%)
Pfizer Receives FDA Approval for SUTENT(R) (sunitinib malate) as First and Only Adjuvant Treatment for Adult Patients at High Risk of Recurrent Renal Cell Carcinoma

Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration has approved a new indication expanding the use of SUTENT(R) (sunitinib malate) to include the adjuvant treatment...

PFE : 35.43 (-0.31%)
AstraZeneca's Faslodex Gets FDA Nod for Use With Verzenio

AstraZeneca's (AZN) drug Faslodex received FDA approval for a new indication.

AZN : 33.83 (+0.30%)
JNJ : 137.29 (-0.76%)
LLY : 83.68 (+0.20%)
PFE : 35.43 (-0.31%)
IRX Therapeutics Appoints Luba Greenwood to Board of Directors

IRX Therapeutics, Inc. (IRX) today announced the appointment of Luba Greenwood, Vice President of Global Business Development and Mergers & Acquisitions at F. Hoffmann-La Roche, Diagnostics,...

PFE : 35.43 (-0.31%)
Novo Nordisk & 4 Other Pharma Stocks in Focus on World Diabetes Day

Despite pricing pressure & competition, the diabetes market remains lucrative given the prevalence of the disease and demand for better treatments. Novo Nordisk (NVO) is a key player in this market.

AZN : 33.83 (+0.30%)
NVO : 51.84 (+0.17%)
MRK : 54.37 (+0.18%)
LLY : 83.68 (+0.20%)
PFE : 35.43 (-0.31%)
SNY : 45.37 (+1.29%)
Merck (MRK) Gets CHMP Nod for Infection Candidate Prevymis

CHMP has given a positive opinion recommending the marketing approval of Merck's (MRK) Prevymis for the prevention of CMV infection.

LGND : 133.06 (+2.33%)
JNJ : 137.29 (-0.76%)
MRK : 54.37 (+0.18%)
PFE : 35.43 (-0.31%)
The Zacks Analyst Blog Highlights: Pfizer, Occidental Petroleum, Charles Schwab, Prudential and S&P Global

The Zacks Analyst Blog Highlights: Pfizer, Occidental Petroleum, Charles Schwab, Prudential and S&P Global

OXY : 68.23 (+0.52%)
PRU : 109.70 (-0.33%)
SPGI : 163.22 (-0.29%)
SCHW : 45.80 (-0.61%)
PFE : 35.43 (-0.31%)
Top Analyst Reports for Pfizer, Occidental Petroleum & Charles Schwab

Top Analyst Reports for Pfizer, Occidental Petroleum & Charles Schwab

OXY : 68.23 (+0.52%)
PRU : 109.70 (-0.33%)
SPGI : 163.22 (-0.29%)
SCHW : 45.80 (-0.61%)
BK : 52.43 (+0.02%)
PFE : 35.43 (-0.31%)
Arena (ARNA) Completes Enrolment in Etrasimod Phase II Study

Arena (ARNA) completed full enrollment with 157 patients in a phase II study evaluating etrasimod in ulcerative colitis (UC). Results from the study are expected in the first quarter of 2018.

LGND : 133.06 (+2.33%)
ARNA : 27.40 (+0.62%)
ABBV : 94.47 (-0.22%)
PFE : 35.43 (-0.31%)
Pfizer Names Albert Bourla Chief Operating Officer

Pfizer Inc. (NYSE: PFE) today announced that Albert Bourla has been named Chief Operating Officer effective January 1, 2018.

PFE : 35.43 (-0.31%)
BMS-Pfizer Alliance to Unveil Real-World Data Analyses - Cost, Safety and Comparative Effectiveness Findings Associated with Oral Anticoagulants in Non-Valvular Atrial Fibrillation

Bristol-Myers Squibb Company (NYSE:BMY) and Pfizer Inc. (NYSE:PFE) plan to release real-world data (RWD) analyses of outcomes associated with direct oral anticoagulants (DOAC) among...

PFE : 35.43 (-0.31%)
BMY : 61.14 (-0.16%)

Van Meerten Stock Picks

My 5 Favorite NASDAQ 100 Stocks
This morning I wanted to find the 5 NASDAQ 100 stocks with the highest Weighted Alpha and the most consistent price appreciation.
HLG -0.70 , ESIO +0.01 , SQ +0.75 , ZAGG -0.65 , OSTK +0.60
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Morning Call

OVERNIGHT MARKETS AND NEWS Dec E-mini S&Ps ( ESZ17 +0.11%) this morning are up +0.03% and European stocks are up +0.12% as strength in energy stocks lifts the overall market. Energy stocks caught a bid after Jan WTI crude oil ( CLF18 +1.72%)... Read More

Chart of the Day

Chart of the Day

Daqo New Energy (DQ) is the Barchart Chart of the Day.  The poly silicon company has a Trend Spotter, a Weighted Alpha of 174.85+ and gained 133.81% in the last year.
Read More

Brugler Ag Report

Today's Commentary

Corn futures ended the pre-Thanksgiving session with most contracts steady to a penny higher. They showed little reaction to last week’s record ethanol production (corn use >111 mbu for the week using a 2.84 gal/bu yield), as huge stocks and...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart